HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 286/2/L388    most recent 00286.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (20) Citing Articles via Google Scholar Google Scholar Articles by Lan, R. S. Articles by Henry, P. J. Search for Related Content PubMed PubMed Citation Articles by Lan, R. S. Articles by Henry, P. J.

Altered expression and in vivo lung function of protease-activated receptors during influenza A virus infection in mice

¹Pharmacology Unit, School of Medicine and Pharmacology, Faculty of Medicine and Dentistry, ²Discipline of Microbiology, School of Biomedical and Chemical Sciences, Faculty of Life Sciences, and ³Western Australian Institute for Medical Research, University of Western Australia, Perth, Australia 6009

Submitted 21 August 2003 ; accepted in final form 24 October 2003

Protease-activated receptors (PARs) are widely distributed in human airways, and recent evidence indicates a role for PARs in the pathophysiology of inflammatory airway disease. To further investigate the role of PARs in airway disease, we determined the expression and function of PARs in a murine model of respiratory tract viral infection. PAR-1, PAR-2, PAR-3, and PAR-4 mRNA and protein were expressed in murine airways, and confocal microscopy revealed colocalization of PAR-2 and cyclooxygenase (COX)-2 immunostaining in basal tracheal epithelial cells. Elevated levels of PAR immunostaining, which was particularly striking for PAR-1 and PAR-2, were observed in the airways of influenza A/PR-8/34 virus-infected mice compared with sham-infected mice. Furthermore, increased PAR-1 and PAR-2 expression was associated with significant changes in in vivo lung function responses. PAR-1 agonist peptide potentiated methacholine-induced increases in airway resistance in anesthetized sham-infected mice (and in indomethacin-treated, virus-infected mice), but no such potentiation was observed in virus-infected mice. PAR-2 agonist peptide transiently inhibited methacholine-induced bronchoconstriction in sham-infected mice, and this effect was prolonged in virus-infected mice. These findings suggest that during viral infection, the upregulation of PARs in the airways is coupled to increased activation of COX and enhanced generation of bronchodilatory prostanoids.

cyclooxygenase; airway resistance; epithelium

This article has been cited by other articles:

				V. Shpacovitch, M. Feld, M. D. Hollenberg, T. A. Luger, and M. Steinhoff Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity J. Leukoc. Biol., June 1, 2008; 83(6): 1309 - 1322. [Abstract] [Full Text] [PDF]

				E. Ostrowska, E. Sokolova, and G. Reiser PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1208 - L1218. [Abstract] [Full Text] [PDF]

				K. Kunzelmann, J. Sun, J. Meanger, N. J. King, and D. I. Cook Inhibition of Airway Na+ Transport by Respiratory Syncytial Virus J. Virol., April 15, 2007; 81(8): 3714 - 3720. [Abstract] [Full Text] [PDF]

				M. Chignard and D. Pidard Neutrophil and Pathogen Proteinases versus Proteinase-Activated Receptor-2 Lung Epithelial Cells: More Terminators than Activators. Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 394 - 398. [Abstract] [Full Text] [PDF]

				P. J. Henry, A. D'Aprile, G. Self, T. Hong, and T. S. Mann Inhibitors of Prostaglandin Transport and Metabolism Augment Protease-Activated Receptor-2-Mediated Increases in Prostaglandin E2 Levels and Smooth Muscle Relaxation in Mouse Isolated Trachea J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 995 - 1001. [Abstract] [Full Text] [PDF]

				K. Kunzelmann and B. McMorran First Encounter: How Pathogens Compromise Epithelial Transport Physiology, October 1, 2004; 19(5): 240 - 244. [Abstract] [Full Text] [PDF]